BioPacific Conference 2011 Agenda
Theme: Emerging Trends and Opportunities in the Biopharmaceutical Industries of the US, China, and Beyond
June 25, 2011, Saturday, Foster City, California
| 8:00 – 9:00am | Registration and Vendor Exhibits |
| 9:00 – 9:05am | Welcome Remarks Janet Xiao, CABS President-Elect, Partner, Morrison & Foerster LLP |
| 9:05 – 9:15am | State of the Society Wei Dong, CABS President, Global Biometrics Head Asia Pacific, Roche |
| Session I: Emerging Trends in the Biopharmaceutical Industry Session Chairs: Cheni Kwok and Shichang Miao |
|
| 9:15 – 9:40am | Douglass Given, Investment Partner, Managing Director and Founder, Bay City Capital “Emerging Trends in the Biopharmaceutical Industry” |
| 9:40 – 10.05am | John Oyler, Founder and CEO of BeiGene, China “New Paradigms for Biopharmaceutical Research and Development in China” |
| 10:05 – 10.30am | Don Ganem VP and Global Head of Infectious Disease, Novartis Institutes of Biomedical Research |
| 10:30 – 10:50am | Chuck Comey, Partner, Morrison & Foerster LLP, Platinum Sponsor |
| 10:50 – 11:10am | Break, Networking, and Vendor Exhibits |
| Session II: New Waves of Drug Discovery and Commercialization Session Chairs: Charlene Liao and John Mao |
|
| 11:10 – 11:35am | Napoleone Ferrara, Genentech Fellow, Genentech “New Insights into the Regulation of Angiogenesis” |
| 11:35 – 12:00am | Neil Desai, Senior VP, Abraxis BioScience LLC, Celgene “Nanotechnology from Bench to the Clinic and Beyond” |
| 12:00 – 12:25pm | Stephen K. Doberstein, Senior VP and Chief Scientific Officer, Nektar Therapeuticsh “New Promises with Polymer-Drug Conjugates” |
| 12:25 – 12:35pm | Connie Sun, Senior VP of Oncology Chemistry, Pharmaron, Gold Sponsor |
| 12:35 – 12:45pm | Jun Li, Chief Scientific Officer, Abgent, Gold Sponsor |
| 12:45 – 1:45pm | Lunch |
| Session III: Global Clinical Development and Product Registration Session Chairs: Wei Dong, Josh Xiao and Charles Liu |
|
| 1:45 – 2:10pm | Frank Shen, Divisional VP of Global Data Management and Statistics, Pharmaceutical R&D, Abbott Laboratories “A Bridge Too Far? Challenges and Opportunities in Linking China into Simultaneous Global Development via Multi-Regional Clinical Trials” |
| 2:10 – 2:35pm | Albert Liou, Vice President and General Manager, PAREXEL International “Prospect of Global Clinical Development Next 10 Years: Asia’s Roles” |
| 2:35 – 3:00pm | Wen Chen, VP of Business Development, TigerMed Consulting, China |
| 3:00 – 3:10pm | Cassandra Boyer, Regional Sales Director, GE Healthcare, Gold Sponsor |
| 3:10 – 3:20pm | Hui Li, Director of Business Development, PPD/BioDuro, Gold Sponsor |
| 3:20 – 3:40pm | Break, Networking, and Vendor Exhibits |
| Session IV: China’s Future in Life Sciences: New Drivers of Innovation Session Chairs: Chi-Hui Tang and Alan Hao |
|
| 3:40 – 4:00pm | Michael Zielenziger, Consultant, Monitor Group “China’s Future in Life Sciences: New Drivers of Innovation” |
| 4:00 – 4:20pm | Sofie Qiao, President, CEO and Co-Founder, LINQ Pharmaceuticals “A Nuanced Balance” |
| 4:20 – 4:40pm | Xiaodong Yang, President and CEO, Apexigen “Managing Strategic Alliances with Partners in China: Apexigen’s Experience” |
| 4:40 – 5:00pm | Reinhard Oesterle, Senior Director of Business Development, SciClone Pharmaceuticals “Building a Leading Specialty Pharma Company in China” |
| 5:00 – 5:10pm | Peter Zhang, CEO, GenePharma, Gold Sponsor |
| 5:10 – 5:40pm | Panel Discussion |
| 5:40 – 6:00pm | Break, Networking, and Vendor Exhibits |
| 6:00 – 7:00pm | Dinner |
| Session V: Crossing the Bridge: Opportunities and Lessons Learned Session Chairs: Hua Tu and Yibing Wang |
|
| 7:00 – 7:15pm | Joy Zhu, Senior VP of Global Clinical Development, S*BIO, Singapore “Leveraging Geographic Location and Development Talent in Drug Developmet – A S*BIO Story” |
| 7:15 – 7:30pm | Joyce Peng, Marketing Director, BGI Americas Corporation “Partnering for Multi-omics Excellence” |
| 7:30 – 7:45pm | Andrew Wong, Director of Corporate Development, Alexza Pharmaceuticals, Inc. “Efficient Creation of Differentiated Therapies-Alexza Pharmaceuticals & the Staccato System” |
| 7:45 – 8:00pm | Dongxiao Zhang, President and CEO, Formurex “Channeling the New Wave of Chinese Pharmaceutical Products to the US Market” |
| 8:00 – 8:15pm | John Wang, President and CEO, ImmuOn, China “China: The Road to Home” |
| 8:15 – 8:30pm | Hua Tu, President and CEO, LakePharma, Inc. “Large Molecule Drug Development in China” |
| 8:30 – 9:00pm | Panel Discussion |
| 9:00pm | Adjourned |